ESTEVE QUÍMICA

ESTEVE QUÍMICA Contract Manufacturing & Development (CDMO) Profile

European contract manufacturing of small molecule intermediates, API and Pharmaceutical intermediates.

Over 50 years of experience serving small molecule APIs to third parties worldwide. Robust systems in place to support clients from early clinical stages, through registration to commercial manufacturing and release.

Since 2007, Esteve has supported customers with 23 NCE filings submitted for worldwide markets.

Highly specialized R&D teams for process development, transfers, scale-up, troubleshooting, etc.

Technical expertise and proactive approach to study cost-saving strategies.

Global sites allowing manufacturing diversification and flexible capacity.

Near 45 years from first FDA inspection. Very robust Quality Systems with global Quality compliance governance.

Well-established supply chain systems, from the quality, service and cost efficiency perspective and offering long-term support to our customers through the lifecycle of the product.

Experience with big and small biotech/pharmaceutical companies from early clinical phases to commercialization to urgent/high-speed tech transfer and validations.

Multidisciplinary core-teams led by Project Management allow an agile and transparent coordination and activity execution.

CDMO Services:
Small Molecule Drug Substance Manufacturing (API); Research & Development; Regulatory Services; Analytical Development

Year Founded: 1929

Head Office: Barcelona, Spain

Number of Facilities: 3-5

Facility locations: Europe; North America; China

Website: Visit the ESTEVE QUÍMICA website

Linkedin: Connect on Linkedin

Current Capacity: 1036m3 reaction capacity.